Form 8-K - Current report:
SEC Accession No. 0001558370-23-012928
Filing Date
2023-08-02
Accepted
2023-08-02 16:20:52
Documents
15
Period of Report
2023-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20230802x8k.htm   iXBRL 8-K 35626
2 EX-99.1 gbio-20230802xex99d1.htm EX-99.1 74595
3 GRAPHIC gbio-20230802xex99d1001.jpg GRAPHIC 6132
  Complete submission text file 0001558370-23-012928.txt   325771

Data Files

Seq Description Document Type Size
4 EX-101.SCH gbio-20230802.xsd EX-101.SCH 3616
5 EX-101.LAB gbio-20230802_lab.xml EX-101.LAB 672
6 EX-101.PRE gbio-20230802_pre.xml EX-101.PRE 9867
9 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20230802x8k_htm.xml XML 4072
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 231135970
SIC: 2834 Pharmaceutical Preparations